ProKidney Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	0.82	0.89	0.08	-	-	-
Revenue Growth	55.22%	1075.00%	-	-	-	-
Gross Profit	0.82	0.89	0.08	-	-	-
Selling, General & Admin	47.12	51.78	50.76	44.82	70.94	8.86
Research & Development	130.92	114.12	127.67	106.71	82.07	46.26
Operating Expenses	178.03	165.9	178.43	151.52	153.01	55.11
Operating Income	-177.22	-165.01	-178.35	-151.52	-153.01	-55.11
Interest Expense	-0.02	-0	-0.01	-0.01	-0.22	-
Interest & Investment Income	10.46	13.81	19.75	22.08	5.98	0
EBT Excluding Unusual Items	-166.78	-151.2	-158.61	-129.45	-147.24	-55.11
Asset Writedown	-	-	-5.32	-	-	-
Pretax Income	-166.78	-151.2	-163.93	-129.45	-147.24	-55.11
Income Tax Expense	-1.03	0.41	-0.6	6	0.9	0.04
Earnings From Continuing Operations	-165.75	-151.61	-163.34	-135.45	-148.14	-55.15
Minority Interest in Earnings	81.59	82.63	102.15	99.98	40.1	-
Net Income	-84.16	-68.99	-61.19	-35.47	-108.03	-55.15
Preferred Dividends & Other Adjustments	-	-	-	-	-93.63	-
Net Income to Common	-84.16	-68.99	-61.19	-35.47	-14.4	-55.15
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	151	134	98	62	62	151
Shares Outstanding (Diluted)	151	134	98	62	62	151
Shares Change	17.54%	36.79%	58.66%	0.28%	-59.17%	43.55%
EPS (Basic)	-0.56	-0.52	-0.62	-0.57	-0.23	-0.37
EPS (Diluted)	-0.56	-0.52	-0.62	-0.57	-0.23	-0.37
EPS Growth	-	-	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	-159.73	-135.31	-155.86	-124.27	-78.94	-55.49
Free Cash Flow Per Share	-1.06	-1.01	-1.59	-2.01	-1.28	-0.37
Gross Margin	100.00%	100.00%	100.00%	-	-	-
Operating Margin	-21664.55%	-18477.83%	-234673.68%	-	-	-
Profit Margin	-10288.39%	-7725.20%	-80507.89%	-	-	-
Free Cash Flow Margin	-19527.38%	-15152.63%	-205078.95%	-	-	-
EBITDA	-170.37	-158.43	-172.92	-147.67	-149.97	-53.13
D&A For EBITDA	6.85	6.58	5.43	3.85	3.04	1.98
EBIT	-177.22	-165.01	-178.35	-151.52	-153.01	-55.11

SEC Filings: 10-K · 10-Q